Mark A. Pallansch

34.8k citations

268 papers · 17.6k indexed · 5 hit papers · h-index 74

Cardiology and Cardiovascular Medicine top 0.05%
Infectious Diseases top 0.02%
Epidemiology top 0.2%
Agronomy and Crop Science top 0.05%
Molecular Biology top 5%

Co-authors: M. Steven Oberste Kaija Maher Olen M. Kew W. Allan Nix Betty A. Brown David R. Kilpatrick Roland W. Sutter Kimberly M. Thompson
Topics: Viral Infections and Immunology Research (242 papers)Viral gastroenteritis research and epidemiology (189 papers)Animal Disease Management and Epidemiology (67 papers)
Cited by: Infectious Diseases Cardiology and Cardiovascular Medicine Agronomy and Crop Science
Journals: Science New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: United States Switzerland Bangladesh

In The Last Decade

Mark A. Pallansch

267 papers receiving 16.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Evolution of the Human Enteroviruses: Correlation of Serotype with VP1 Sequence and Application to Picornavirus Classification

1999 722 citations M. Steven Oberste, Kaija Maher et al. profile →
Sensitive, Seminested PCR Amplification of VP1 Sequences for Direct Identification of All Enterovirus Serotypes from Original Clinical Specimens

2006 703 citations M. Steven Oberste, Mark A. Pallansch et al. profile →
Enterovirus Surveillance - United States, 1970-2005

2006 550 citations Nino Khetsuriani, M. Steven Oberste et al. profile →
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION

2005 501 citations Olen M. Kew, Roland W. Sutter et al. profile →
ICTV Virus Taxonomy Profile: Picornaviridae

2017 390 citations Mark A. Pallansch et al. profile →

Peers

Countries citing papers authored by Mark A. Pallansch

Since Specialization

Citations

This map shows the geographic impact of Mark A. Pallansch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Pallansch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Pallansch more than expected).

Fields of papers citing papers by Mark A. Pallansch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Pallansch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Pallansch. The network helps show where Mark A. Pallansch may publish in the future.

Co-authorship network of co-authors of Mark A. Pallansch

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Pallansch. A scholar is included among the top collaborators of Mark A. Pallansch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Pallansch. Mark A. Pallansch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial 2023 ·Vaccine ·Cynthia J. Snider,Khalequ Zaman,Amanda L. Wilkinson,Asma Binte Aziz,(unknown),(unknown),(unknown),Ling Wei,Concepción F. Estívariz,Jennifer L. Konopka‐Anstadt,Bernardo A. Mainou,Jaymin C. Patel,(unknown),Mark A. Pallansch,Steven G. F. Wassilak,M. Steven Oberste,Abhijeet Anand	3
2	Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences 2023 ·Risk Analysis ·Dominika A. Kalkowska,Steven G. F. Wassilak,Eric Wiesen,Cara C. Burns,Mark A. Pallansch,Kamran Badizadegan,Kimberly M. Thompson	13
3	Outbreak response strategies with type 2-containing oral poliovirus vaccines 2022 ·Vaccine ·Dominika A. Kalkowska,Steven G.F. Wassilak,Mark A. Pallansch,Cara C. Burns,Eric Wiesen,(unknown),Kamran Badizadegan,Kimberly M. Thompson	15
4	The impact of disruptions caused by the COVID-19 pandemic on global polio eradication 2021 ·Vaccine ·Dominika A. Kalkowska,Arend Voorman,Mark A. Pallansch,Steven G.F. Wassilak,Stephen L. Cochi,Kamran Badizadegan,Kimberly M. Thompson	30
5	Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine 2020 ·Science ·Grace Macklin,Kathleen O’Reilly,Nicholas C. Grassly,W. John Edmunds,Ondrej Mach,(unknown),(unknown),John Vertefeuille,J. Abdelwahab,Nicksy Gumede,Ajay Kumar Goel,Stephen Sosler,John L. Sever,Ananda S Bandyopadhyay,Mark A. Pallansch,Robin Nandy,Pascal Mkanda,Ousmane M. Diop,Roland W. Sutter	87
6	Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis 2019 ·BMJ Open ·Radboud J. Duintjer Tebbens,Ousmane M. Diop,Mark A. Pallansch,M. Steven Oberste,Kimberly M. Thompson	9
7	Effect of time at temperature on wild poliovirus titers in stool specimens 2015 ·Virology ·Allison Taylor Walker,A. J. Williams,Howard E. Gary,Mark A. Pallansch,Steven G. F. Wassilak,M. Steven Oberste	5
8	Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs 2015 ·BMC Infectious Diseases ·Radboud J. Duintjer Tebbens,Mark A. Pallansch,Kimberly M. Thompson	44
9	Efficacy of inactivated poliovirus vaccine in India 2014 ·Science ·Hamid Jafari,Jagadish M. Deshpande,Roland W. Sutter,Sunil Bahl,Harish Verma,M. Ridwan Said Ahmad,Abhishek Kunwar,(unknown),Ashutosh Agarwal,Shilpi Jain,Concepción F. Estívariz,Raman Sethi,Natalie A. Molodecky,Nicholas C. Grassly,Mark A. Pallansch,(unknown),(unknown)	90
10	Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination 2014 ·The Journal of Infectious Diseases ·Peter F. Wright,Wendy Wieland‐Alter,Natalia A. Ilyushina,Anne Gatewood Hoen,Minetaro Arita,Austin W. Boesch,Margaret E. Ackerman,Harrie van der Avoort,M. Steven Oberste,Mark A. Pallansch,Anthony Burton,(unknown),Roland W. Sutter	38
11	Progress in the Development of Poliovirus Antiviral Agents and Their Essential Role in Reducing Risks That Threaten Eradication 2014 ·The Journal of Infectious Diseases ·M A McKinlay,Marc S. Collett,(unknown),(unknown),Mark A. Pallansch,Hiromasa Okayasu,Roland W. Sutter,John F. Modlin,Walter R. Dowdle	43
12	Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis 2007 ·Human Pathology ·Jeannette Guarner,Julu Bhatnagar,Wun‐Ju Shieh,Kurt B. Nolte,Dennis Klein,(unknown),Silvia Peñaranda,M. Steven Oberste,Tara L. Jones,(unknown),Mark A. Pallansch,Sherif R. Zaki	29
13	Imported vaccine-associated paralytic poliomyelitis - United States, 2005. 2006 ·MMWR Morbidity and Mortality Weekly Report ·Mauricio Landaverde,(unknown),(unknown),(unknown),R. J. Walker,(unknown),(unknown),Laura M. Erhart,Simon Anderson,(unknown),Mark A. Pallansch,James J. Sejvar,(unknown),(unknown),Lorraine N. Alexander,Jane F. Seward	20
14	Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. 2004 ·PubMed ·Neal A. Halsey,Jorge Pinto,Francisco Espinosa‐Rosales,(unknown),Edson da Silva,Aamir Khan,A D Webster,Philip D. Minor,Glynis Dunn,Edwin J. Asturias,Hamidah Hussain,Mark A. Pallansch,Olen M. Kew,Jerry A. Winkelstein,Roland W. Sutter	86
15	Genomic evidence that simian virus 2 and six other simian picornaviruses represent a new genus in Picornaviridae 2003 ·Virology ·M. Steven Oberste,Kaija Maher,Mark A. Pallansch	45
16	Persistence of Vaccine‐Derived Polioviruses among Immunodeficient Persons with Vaccine‐Associated Paralytic Poliomyelitis 2003 ·The Journal of Infectious Diseases ·Nino Khetsuriani,D. Rebecca Prevots,Linda Quick,Melissa E. Elder,Mark A. Pallansch,Olen M. Kew,Roland W. Sutter	78
17	New‐onset juvenile dermatomyositis. Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis 1997 ·Arthritis & Rheumatism ·Lauren M. Pachman,Jennifer R. Hayford,Marc C. Hochberg,Mark A. Pallansch,(unknown),(unknown),Balu H. Athreya,Suzanne L. Bowyer,Chester W. Fink,Harry L. Gewanter,Rita Jerath,Bianca Lang,Ilona S. Szer,James Sinacore,Mary Christensen,Alan R. Dyer	38
18	A Theoretical Framework for Evaluating the Sensitivity of Surveillance for Detecting Wild Poliovirus: I. Factors Affecting Detection Sensitivity in a Person with Acute Flaccid Paralysis 1997 ·The Journal of Infectious Diseases ·Howard E. Gary,Ronald C. Sanders,Mark A. Pallansch	12
19	Lack of detection of enteroviral rna or bacterial dna in magnetic resonance imaging–directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis 1995 ·PubMed ·Lauren M. Pachman,(unknown),Anne H. Rowley,Jennifer R. Hayford,(unknown),(unknown),Baruch S. Ticho,Mary Christensen,Bruce Patterson,Steven R. Ytterberg,Mark A. Pallansch	38
20	Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis 1990 ·Journal of the American College of Cardiology ·Steven Tracy,V. Wiegand,Bruce M. McManus,Charles J. Gauntt,Mark A. Pallansch,Melinda A. Beck,Nora M. Chapman	90

About Mark A. Pallansch

Mark A. Pallansch is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Agronomy and Crop Science, having authored 268 papers that have together received 17.6k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (242 papers), Viral gastroenteritis research and epidemiology (189 papers) and Animal Disease Management and Epidemiology (67 papers). The work is most often cited by research in Infectious Diseases (12.5k citations), Cardiology and Cardiovascular Medicine (14.4k citations) and Agronomy and Crop Science (3.5k citations). Mark A. Pallansch has collaborated with scholars based in United States, Switzerland and Bangladesh. Frequent co-authors include M. Steven Oberste, Kaija Maher, Olen M. Kew, W. Allan Nix, Betty A. Brown, David R. Kilpatrick, Roland W. Sutter, Kimberly M. Thompson, Radboud J. Duintjer Tebbens and James P. Alexander. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact